WJ, K., & RW, C. (2020). Comment on "Replacing the NCCN's Blocks with Wheels: How Should Consideration of Societal Spending be Incorporated into Oncology Practice?". PharmacoEconomics, 38(8), 893. https://doi.org/10.1007/s40273-020-00938-y
Chicago Style (17th ed.) CitationWJ, Koh, and Carlson RW. "Comment on "Replacing the NCCN's Blocks with Wheels: How Should Consideration of Societal Spending Be Incorporated into Oncology Practice?"." PharmacoEconomics 38, no. 8 (2020): 893. https://doi.org/10.1007/s40273-020-00938-y.
MLA (9th ed.) CitationWJ, Koh, and Carlson RW. "Comment on "Replacing the NCCN's Blocks with Wheels: How Should Consideration of Societal Spending Be Incorporated into Oncology Practice?"." PharmacoEconomics, vol. 38, no. 8, 2020, p. 893, https://doi.org/10.1007/s40273-020-00938-y.